National Security | BIO

Biotech is a National Security Imperative

America's biotech dominance doesn't just help save lives and grow the economy -
it also safeguards our national security.

Protecting Our Leadership

Throughout the last 50 years, America's historic biotech leadership has allowed the United States to influence how powerful technologies are developed, regulated, and deployed globally. But our leadership is not promised. The bipartisan National Security Commission on Emerging Biotechnology (NSCEB) has warned that China is rapidly closing the innovation gap with the United States. These actions threaten not only U.S. competitiveness, but also the long-term health security of American patients and that of our allies.

Placeholder Image

China currently manufactures 8% of the active pharmaceutical ingredients in American-consumed medicines.

China now accounts for 30% of the global innovative drug pipeline, barely trailing America's 36% share.

Chinese theft of American intellectual property, including from the biotech sector, costs Americans an estimated $600 billion each year.